Anavex Life Sciences recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use delivered a negative trend vote on the Marketing Authorisation Application ...

Airbnb ( ABNB +0.71%) is a battleground stock. Either you love or hate the disruptive home-sharing platform, which went ...

An announcement from Moonpig Group Plc ( ($GB:MOON) ) is now available. Moonpig Group plc announced the repurchase and cancellation of 123,425 ...

Nvidia (NASDAQ: NVDA) recently held its GTC conference in Washington, D.C., and CEO Jensen Huang made several big ...

Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...

The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Read more ...

IonQ's competitor D-Wave may have an advantage in bringing quantum computers to AI due to its focus on technology called ...

Michael Hartnett, Chief Investment Strategist at BofA Merrill Lynch Global Research, sees stocks maintaining their momentum ...

Legence jumps on its Bowers deal boosting revenue, profits and data-center exposure with strong growth and strategy execution ...

The longest government shutdown in U.S. history officially ended on Wednesday, but anxiety about tech valuations and Fed rate ...

Data shows that it jumped from $13.57 billion in 2023 to $15.30 billion in 2024. Contractors are scrambling to keep up with ...

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver ...